The Hematopoietic Stem Cell Transplantation Donor

The Hematopoietic Stem Cell Transplantation Donor is a comprehensive, internationally authored reference dedicated to the scientific, clinical, and ethical aspects of hematopoietic stem cell donation. Developed through a joint initiative of the this book brings together international expertise to advance donor care, safety, and transplantation practices worldwide.

Covering the entire donor journey, from identification and selection to long-term follow-up, the book addresses HLA matching, donor evaluation and eligibility, stem cell mobilization and collection, and the roles of related and unrelated donors and international donor registries. Dedicated chapters explore the unique challenges associated with older donors, minors, and pregnant donors, alongside donor safety, serious adverse reactions, and emerging research priorities.

Emphasizing evidence-based practices, ethical considerations, and international collaboration, this volume provides a valuable resource for transplant physicians, hematologists, donor registry professionals, transplant coordinators, researchers, and healthcare policymakers.

Published as an open-access resource, the book ensures unrestricted worldwide access to essential knowledge, supporting education, harmonization of donor practices, and equitable access to transplantation while promoting the highest standards of donor safety and care.

Dr. Mahmoud Aljurf is Director of the Adult Hematopoietic Stem Cell Transplantation (HSCT) and Cellular Therapy Program at King Faisal Specialist Hospital & Research Centre (KFSHRC), Riyadh, Saudi Arabia. His clinical and academic work spans hematologic malignancies, hematopoietic stem cell transplantation, cellular therapy, and the development of transplant programs.
He completed his internship at King Khalid University Hospital, followed by residency training in internal medicine at Brigham and Women’s Hospital, Harvard Medical School, and fellowship training in hematology and oncology at Stanford University Medical Center. He subsequently earned a master’s degree in health policy and management from the Johns Hopkins Bloomberg School of Public Health. His qualifications include American Board certifications in Internal Medicine, Medical Oncology, and Hematology, as well as Fellowship of the Royal College of Pathologists (FRCPath), United Kingdom. He also holds credentials in medical management and quality assurance.
Dr. Aljurf joined KFSHRC in 1994 and was appointed Head of Adult Hematology and HSCT in 1996. He subsequently served as Deputy Director of the Oncology Center and has led the development of one of the world's largest allogeneic HSCT programs, currently performing approximately 400 allogeneic transplants annually, with the total number of cellular therapy procedures approaching 600 per year.
His scholarly contributions include nearly 600 peer-reviewed publications, as well as contributions to clinical practice guidelines and initiatives to improve access to transplantation. He is the founder and Editor-in-Chief of the journal Hematology/Oncology and Stem Cell Therapy and previously served as Editor-in-Chief of the Annals of Saudi Medicine. He also serves on the International Advisory Board of The Lancet Haematology.
His international leadership includes his election as President of the Worldwide Network for Blood & Marrow Transplantation (WBMT) and his service as a founding member and Scientific Director of the Eastern Mediterranean Blood and Marrow Transplantation (EMBMT) Group.

Jörg Halter

Universitätsspital Basel

Mickey B C Koch

St George's University Hospitals

Institute for Infection and Immunity

St. George's, University of London

Annalisa Ruggeri

Davison of Haematology

IRCCS San Raffaele Hospital

Dietger W. Niederwieser

Professor of Medicine and the Head of the Division of Hematology and Oncology

University Hospital Leipzig, Germany

Nina Worel

Department for Transfusion Medicine and Cell Therapy

Medical University of Vienna